BiotechBiotech

IPOs are up in the year to date. But the value of these deals is down. Rather than cashing out, VCs are getting a ticket to stay on for a white-knuckle ride.

News Editor Thomas Lau spoke to Florian Schönharting, a partner at the Nordic Biotech, a fund that has invested in Denmark’s Gastrotech BipPharma - a biotechnology company that recently merged with US biotech firm DOR BioPharma. Nordic Biotech, a specialised biotech venture capital fund focusing primarily on Nordic countries and the EU, has invested in Gastrotech since its inception in March 2003.